Acute Hypoxemic Respiratory Failure

Respiratory
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Hamilton medical
Hamilton medicalSwitzerland - Bonaduz
1 program
Closed-loop FiO2 controllerN/A1 trial
Active Trials
NCT06374589RecruitingEst. May 2026
Lungpacer Medical
Lungpacer MedicalBC - Vancouver
1 program
Lungpacer AeroPace Protect SystemN/A1 trial
Active Trials
NCT05465083CompletedEst. Nov 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Hamilton medicalClosed-loop FiO2 controller
Lungpacer MedicalLungpacer AeroPace Protect System

Clinical Trials (2)

NCT06374589Hamilton medicalClosed-loop FiO2 controller

Closed-Loop O2 Use During High Flow Oxygen Treatment of Critical Care Adult Patients (CLOUDHFOT)

Start: Mar 2024Est. completion: May 2026
N/ARecruiting
NCT05465083Lungpacer MedicalLungpacer AeroPace Protect System

Feasibility of Transvenous Phrenic Nerve Stimulation for Diaphragm Protection in Acute Respiratory Failure

Start: Feb 2023Est. completion: Nov 2023
N/ACompleted

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space